GRADE guidelines: 15. Going from evidence to recommendation - Determinants of a recommendation's direction and strength

Journal of Clinical Epidemiology

Volumn 66, Issue 7, 2013, Pages 726-735

  Andrews, Jeffrey C ^a   Schünemann, Holger J ^b   Oxman, Andrew D ^c   Pottie, Kevin ^d   Meerpohl, Joerg J ^e   Coello, Pablo Alonso ^f,g   Rind, David ^h   Montori, Victor M ⁱ   Brito, Juan Pablo ⁱ   Norris, Susan ^j   Elbarbary, Mahmoud ^k   Post, Piet ^l   Nasser, Mona ^m   Shukla, Vijay ⁿ   Jaeschke, Roman ^b   Brozek, Jan ^b   Djulbegovic, Ben ^o,p   Guyatt, Gordon ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF FREIBURG   (Germany)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ MAYO CLINIC   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k KING SAUD UNIVERSITY   (Saudi Arabia)

^l Post voor Zorg   (Netherlands)

^m PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

ⁿ CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH   (Canada)

^o UNIVERSITY OF SOUTH FLORIDA   (United States)

^p H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

more..

Author keywords

Evidence; GRADE; Guideline development; Quality of evidence; Recommendation; Strength of evidence

Indexed keywords

ARTICLE; DECISION MAKING; HEALTH CARE PERSONNEL; HUMAN; NOMENCLATURE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL;

CANADA; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

EID: 84878229656     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.02.003     Document Type: Article

References (44)

1. G. Guyatt, A. Oxman, R. Kunz, D. Atkins, J. Brozek, and G. Vist GRADE guidelines: 2. Framing the question and deciding on important outcomes J Clin Epidemiol 64 2011 395 400
2. H. Balshem, M. Helfand, H.J. Schunemann, A.D. Oxman, R. Kunz, and J. Brozek GRADE guidelines: 3. Rating the quality of evidence J Clin Epidemiol 64 2011 401 406
3. G.H. Guyatt, A.D. Oxman, G. Vist, R. Kunz, J. Brozek, and P. Alonso-Coello GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias) J Clin Epidemiol 64 2011 407 415
4. G.H. Guyatt, A.D. Oxman, V. Montori, G. Vist, R. Kunz, and J. Brozek GRADE guidelines: 5. Rating the quality of evidence-publication bias J Clin Epidemiol 64 2011 1277 1282
5. G. Guyatt, A.D. Oxman, R. Kunz, J. Brozek, P. Alonso-Coello, and D. Rind GRADE guidelines 6. Rating the quality of evidence - imprecision J Clin Epidemiol 64 2011 1283 1293
6. G.H. Guyatt, A.D. Oxman, R. Kunz, J. Woodcock, J. Brozek, and M. Helfand GRADE guidelines: 7. Rating the quality of evidence-inconsistency J Clin Epidemiol 64 2011 1294 1302
7. G.H. Guyatt, A.D. Oxman, R. Kunz, J. Woodcock, J. Brozek, and M. Helfand GRADE guidelines: 8. Rating the quality of evidence-indirectness J Clin Epidemiol 64 2011 1303 1310
8. G.H. Guyatt, A.D. Oxman, S. Sultan, P. Glasziou, E.A. Akl, and P. Alonso-Coello GRADE guidelines: 9. Rating up the quality of evidence J Clin Epidemiol 64 2011 1311 1316
9. M. Brunetti, I. Shemilt, S. Pregno, L. Vale, A. Oxman, and J. Lord GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence J Clin Epidemiol 66 2013 140 150
10. G.H. Guyatt, A.D. Oxman, S. Sultan, J. Brozek, P. Glasziou, and P. Alonso-Coello GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes J Clin Epidemiol 64 2013 151 157
11. G.H. Guyatt, A.D. Oxman, N. Santesso, M. Helfand, G. Vist, and R. Kunz GRADE guidelines: 12. Preparing summary of findings tables: binary outcomes J Clin Epidemiol 66 2013 158 172
12. G.H. Guyatt, K. Thorlund, A.D. Oxman, S. Walter, D. Patrick, and T.A. Furukawa GRADE guidelines: 13. Preparing summary of findings tables: continuous outcomes J Clin Epidemiol 66 2013 173 183
13. G. Guyatt, A. Oxman, E. Akl, R. Kunz, G. Vist, and J. Brozek GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables J Clin Epidemiol 64 2011 383 394
14. J. Andrews, G. Guyatt, A.D. Oxman, P. Alderson, P. Dahm, and Y. Falck-Ytter GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations J Clin Epidemiol 66 2013 719 725
15. J.M. Eisenberg Globalize the evidence, localize the decision: evidence-based medicine and international diversity Health Aff (Millwood) 21 3 2002 166 168
16. H.J. Schunemann, M. Woodhead, A. Anzueto, S. Buist, W. Macnee, and K.F. Rabe A vision statement on guideline development for respiratory disease: the example of COPD Lancet 373 2009 774 779
17. V. Montori, P. Devereaux, S. Straus, B. Haynes, and G. Guyatt Decision making and the patient G. Guyatt, The users' guides to the medical literature: a manual for evidence-based clinical practice 2nd ed. 2008 McGraw-Hill New York, NY
18. S. McLean, S. Mulla, E.A. Akl, M. Jankowski, P. Vandvik, and S. Ibrahim Patient values and preferences in decision making for antithrombotic therapy: a systematic review. Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e1S e23S
19. K. Pottie, C. Greenaway, J. Feightner, V. Welch, H. Swinkels, and M. Rashid Evidence-based clinical guidelines for immigrants and refugees CMAJ 183 12 2011 E824 E925
20. S. Bates, I. Greer, S. Middeldorp, D. Veenstra, A. Prabulos, and P. Vandvik VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e691S e736S
21. S.G. Goodman, V. Menon, C.P. Cannon, G. Steg, E.M. Ohman, and R.A. Harrington Acute ST-segment elevation myocardial infarction: American College of Chest physicians evidence-based clinical practice guidelines (8th Edition) Chest 133 6 Suppl 2008 708S 775S
22. A. Webster, R. Woodroffe, R. Taylor, J. Chapman, and J. Craig Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients Cochrane Database Syst Rev 4 2006 CD003961
23. P.J. Devereaux, D.R. Anderson, M.J. Gardner, W. Putnam, G.J. Flowerdew, and B.F. Brownell Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study BMJ 323 2001 1218 1222
24. Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians Ann Intern Med 117 1992 1038 1041
25. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, and B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
26. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
27. S.W. Chapman, W.E. Dismukes, L.A. Proia, R.W. Bradsher, P.G. Pappas, and M.G. Threlkeld Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America Clin Infect Dis 46 2008 1801 1812
28. T.C. Lauenstein, and R.C. Semelka Emerging techniques: whole-body screening and staging with MRI J Magn Reson Imaging 24 3 2006 489 498
29. P. Malfertheiner, F. Megraud, C. O'Morain, F. Bazzoli, E. El-Omar, and D. Graham Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 56 6 2007 772 781
30. L.A. Magee, M. Helewa, J.M. Moutquin, P. van Dadelszen, and for the Hypertension Guideline Committee Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Clinical Practice Guideline, No. 206, March 2008 J Obstet Gynaecol Can 30 2008 S1 S48
31. S. Bhasin, G. Cunningham, F. Hayes, A. Matsumoto, P. Snyder, and R. Swerdloff Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2010 2536 2559
32. H.J. Schunemann, S.R. Hill, M. Kakad, R. Bellamy, T.M. Uyeki, and F.G. Hayden WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus Lancet Infect Dis 7 2007 21 31
33. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e419S e494S
34. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 149 2008 627 637
35. B. Levin, D.A. Lieberman, B. McFarland, K.S. Andrews, D. Brooks, and J. Bond Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 5 2008 1570 1595
36. Guidance on surveillance for people at increased risk of colorectal cancer 2012 New Zealand Guidelines Group Wellington, New Zealand
37. P. Tugwell, K. Pottie, V. Welch, E. Ueffing, A. Chambers, and J. Feightner Evaluation of evidence-based literature and formulation of recommendations for the clinical preventive guidelines for immigrants and refugees in Canada CMAJ 183 12 2011 E933 E938
38. H.J. Schunemann, S.R. Hill, M. Kakad, G.E. Vist, R. Bellamy, and L. Stockman Transparent development of the WHO rapid advice guidelines PLoS Med 4 5 2007 e119
39. A.D. Oxman, P. Glasziou, and J.W. Williams Jr. What should clinicians do when faced with conflicting recommendations? BMJ 337 2008 a2530
40. G. Georg, I. Colombet, P. Durieux, J. Menard, and P. Meneton A comparative analysis of four clinical guidelines for hypertension management J Hum Hypertens 22 12 2008 829 837
41. J. Matthys, M. De Meyere, M.L. van Driel, and A. De Sutter Differences among international pharyngitis guidelines: not just academic Ann Fam Med 5 5 2007 436 443
42. H.M. Kaafarani, P.V. Atluri, J. Thornby, and K.M. Itani beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk Arch Surg 143 2008 940 944 discussion 944
43. F. van Lier, O. Schouten, R.T. van Domburg, P.J. van der Geest, E. Boersma, and L.A. Fleisher Effect of chronic beta-blocker use on stroke after noncardiac surgery Am J Cardiol 104 2009 429 433
44. S. Bangalore, J. Wetterslev, S. Pranesh, S. Sawhney, C. Gluud, and F.H. Messerli Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis Lancet 372 2008 1962 1976